Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 3
1949 3
1950 6
1951 5
1952 7
1953 5
1954 2
1955 4
1956 3
1957 8
1958 8
1959 7
1960 4
1961 9
1962 9
1963 14
1964 20
1965 13
1966 8
1967 16
1968 20
1969 15
1970 22
1971 17
1972 24
1973 26
1974 31
1975 36
1976 30
1977 21
1978 24
1979 40
1980 11
1981 12
1982 30
1983 28
1984 32
1985 33
1986 24
1987 43
1988 28
1989 55
1990 91
1991 83
1992 87
1993 72
1994 100
1995 98
1996 90
1997 80
1998 86
1999 100
2000 104
2001 93
2002 133
2003 136
2004 146
2005 213
2006 219
2007 263
2008 261
2009 341
2010 370
2011 370
2012 448
2013 412
2014 501
2015 541
2016 513
2017 539
2018 603
2019 632
2020 772
2021 759
2022 747
2023 739
2024 306

Text availability

Article attribute

Article type

Publication date

Search Results

10,367 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for psoriasis spondylitis
Search for psoriasis spondylitica instead (1 results)
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment.
Brüner M, Dige A, Loft AG, Laurberg TB, Agnholt JS, Clemmensen K, McInnes I, Lories R, Iversen L, Hjuler KF, Kragstrup TW. Brüner M, et al. Autoimmun Rev. 2021 Feb;20(2):102731. doi: 10.1016/j.autrev.2020.102731. Epub 2020 Dec 14. Autoimmun Rev. 2021. PMID: 33326852 Review.
Axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis, inflammatory bowel disease (IBD), and noninfectious uveitis form a distinct group among the immune mediated inflammatory diseases. Thus, many patients suffer from more than one of these disease manifest …
Axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis, inflammatory bowel disease (IBD), and noninfectious uveitis fo …
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.
Gottlieb AB, Deodhar A, Mcinnes IB, Baraliakos X, Reich K, Schreiber S, Bao W, Marfo K, Richards HB, Pricop L, Shete A, Trivedi V, Keefe D, Papavassilis CC, Jagiello P, Papanastasiou P, Mease PJ, Lebwohl M. Gottlieb AB, et al. Acta Derm Venereol. 2022 Apr 27;102:adv00698. doi: 10.2340/actadv.v102.563. Acta Derm Venereol. 2022. PMID: 35146532 Free PMC article.
Secukinumab, a selective interleukin (IL)-17A inhibitor, is approved for use in adult and paediatric psoriasis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis. ...Analyses included 12,637 secukinumab-treated patients, corres …
Secukinumab, a selective interleukin (IL)-17A inhibitor, is approved for use in adult and paediatric psoriasis, psoriatic arthritis, …
Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Chandran V. Chandran V. Curr Opin Rheumatol. 2019 Jul;31(4):329-334. doi: 10.1097/BOR.0000000000000609. Curr Opin Rheumatol. 2019. PMID: 31135567 Review.
This review aims to summarize the current understanding of the differences between ankylosing spondylitis and axPsA. RECENT FINDINGS: Recent observational studies have shown that axPsA forms part of the SpA spectrum, flanked by peripheral PsA on one side and ankylosing …
This review aims to summarize the current understanding of the differences between ankylosing spondylitis and axPsA. RECENT FINDINGS: …
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, Chau J, Eder L, Fernández-Ávila DG, FitzGerald O, Garg A, Gladman DD, Goel N, Helliwell PS, Husni ME, Jadon DR, Katz A, Laheru D, Latella J, Leung YY, Lindsay C, Lubrano E, Mazzuoccolo LD, Mease PJ, O'Sullivan D, Ogdie A, Olsder W, Palominos PE, Schick L, Steinkoenig I, de Wit M, van der Windt DA, Kavanaugh A; GRAPPA Treatment Recommendations domain subcommittees. Coates LC, et al. Nat Rev Rheumatol. 2022 Aug;18(8):465-479. doi: 10.1038/s41584-022-00798-0. Epub 2022 Jun 27. Nat Rev Rheumatol. 2022. PMID: 35761070 Free PMC article. Review.
Since the second version of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic options for psoriatic arthritis (PsA) have advanced considerably. ...Literature searches covered tr …
Since the second version of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendat …
Psoriasis and psoriatic arthritis overview.
Menter A. Menter A. Am J Manag Care. 2016 Jun;22(8 Suppl):s216-24. Am J Manag Care. 2016. PMID: 27356193 Free article. Review.
Effective management requires timely diagnosis and initiation of treatment. Yet, both psoriasis and PsA remain underrecognized and undertreated in current clinical practice. Recognizing the true physical, social, and emotional burden of psoriasis and PsA, as well as …
Effective management requires timely diagnosis and initiation of treatment. Yet, both psoriasis and PsA remain underrecognized and un …
Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.
Scher JU, Ogdie A, Merola JF, Ritchlin C. Scher JU, et al. Nat Rev Rheumatol. 2019 Mar;15(3):153-166. doi: 10.1038/s41584-019-0175-0. Nat Rev Rheumatol. 2019. PMID: 30742092 Review.
Psoriasis is one of the most common chronic inflammatory skin diseases, affecting 3% of the world's population, and approximately one-third of patients with psoriasis will eventually transition to having psoriatic arthritis (PsA). ...Genetic and clinical-demographic …
Psoriasis is one of the most common chronic inflammatory skin diseases, affecting 3% of the world's population, and approximately one …
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
Deodhar A, Mease PJ, McInnes IB, Baraliakos X, Reich K, Blauvelt A, Leonardi C, Porter B, Das Gupta A, Widmer A, Pricop L, Fox T. Deodhar A, et al. Arthritis Res Ther. 2019 May 2;21(1):111. doi: 10.1186/s13075-019-1882-2. Arthritis Res Ther. 2019. PMID: 31046809 Free PMC article.
BACKGROUND: Secukinumab, a fully human immunoglobulin G1-kappa monoclonal antibody that directly inhibits interleukin (IL)-17A, has been shown to have robust efficacy in the treatment of moderate-to-severe psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spond …
BACKGROUND: Secukinumab, a fully human immunoglobulin G1-kappa monoclonal antibody that directly inhibits interleukin (IL)-17A, has been sho …
Psoriatic Arthritis: Pathogenesis and Targeted Therapies.
Azuaga AB, Ramírez J, Cañete JD. Azuaga AB, et al. Int J Mol Sci. 2023 Mar 3;24(5):4901. doi: 10.3390/ijms24054901. Int J Mol Sci. 2023. PMID: 36902329 Free PMC article. Review.
Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis. ...
Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthr …
Psoriatic arthritis.
López-Ferrer A, Laiz A, Puig L. López-Ferrer A, et al. Med Clin (Barc). 2022 Jul 8;159(1):40-46. doi: 10.1016/j.medcli.2022.01.024. Epub 2022 May 4. Med Clin (Barc). 2022. PMID: 35525675 Review. English, Spanish.
The diagnosis of PsA is sometimes difficult due to an enormous clinical and radiological variability, including six different domains of involvement: peripheral joint, axial skeleton, skin psoriasis, nail psoriasis, enthesitis and dactylitis. Currently, there are no …
The diagnosis of PsA is sometimes difficult due to an enormous clinical and radiological variability, including six different domains of inv …
10,367 results
You have reached the last available page of results. Please see the User Guide for more information.